John A. Scarlett's Insider Trades & SAST Disclosures

John A. Scarlett's most recent trade in Geron Corp. was a trade of 12,500 Common Stock done at an average price of $1.8 . Disclosure was reported to the exchange on Feb. 27, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Purchase of securities on an exchange or from another person at price $ 1.77 per share. 27 Feb 2025 12,500 12,500 (0%) 0% 1.8 22,063 Common Stock
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2025 2,457,000 2,457,000 - - Stock Option (right to buy)
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2025 410,000 410,000 - - Restricted Stock Units
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 1,000,000 1,000,000 - - Employee Stock Option (right to buy)
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.54 per share. 04 Jun 2024 600,000 600,000 (0%) 0% 2.5 1,524,000 Common Stock
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jun 2024 600,000 0 - - Stock Option (right to buy)
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 4.00 per share. 04 Jun 2024 600,000 600,000 (0%) 0% 4 2,400,000 Common Stock
Geron Corp.
Scarlett A. John Director, CHAIRMAN, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2024 3,000,000 3,000,000 - - Employee Stock Option (Right to Buy)
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2023 1,750,000 1,750,000 - - Employee Stock Option (Right to buy)
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. 08 Feb 2023 446,668 446,668 (0%) 0% 1.5 670,002 Common Stock
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 3.00 per share. 08 Feb 2023 446,668 0 (0%) 0% 3 1,340,004 Common Stock
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2023 446,668 0 - - Employee Stock Option (right to buy)
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 3.03 per share. 08 Feb 2023 446,666 0 (0%) 0% 3.0 1,353,398 Common Stock
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. 08 Feb 2023 446,666 446,666 (0%) 0% 1.5 669,999 Common Stock
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Sale of securities on an exchange or to another person at price $ 3.08 per share. 08 Feb 2023 446,666 0 (0%) 0% 3.1 1,375,731 Common Stock
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. 08 Feb 2023 446,666 446,666 (0%) 0% 1.5 669,999 Common Stock
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2023 446,666 0 - - Employee Stock Option (right to buy)
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Feb 2023 446,666 0 - - Employee Stock Option (right to buy)
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2022 2,100,000 2,100,000 - - Employee Stock Option (Right to buy)
CytomX Therapeutics Inc
John A. Scarlett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 20,000 20,000 - - Stock Option (Right to Buy)
Geron Corp.
John A. Scarlett Director, Chairman, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2021 600,000 600,000 - - Employee Stock Option (Right to buy)
CytomX Therapeutics Inc
John A. Scarlett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2020 20,000 20,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades